Elekta notifies shareholders of its Annual General Meeting
The meeting will be held on September 3, 2026, in Stockholm, with proposals on dividend, share buyback, and board elections
See the latest news and media coverage for Elekta. We track all announcements, press releases, and industry mentions in real time, all in one place.
Precision radiotherapy solutions provider
elekta.comLast updated
In short: Elekta appointed Jakob Just-Bomholt as CEO, secured FDA clearance for the Evo CT-Linac, and implemented a major cost-savings program.
The meeting will be held on September 3, 2026, in Stockholm, with proposals on dividend, share buyback, and board elections
The report includes audited statutory annual report, sustainability statement, corporate governance report, and remuneration report.
Mid-term targets include mid-single-digit CAGR sales and 14–16% adjusted EBIT by FY 2028/29. FY 2026/27 outlook: sales +2–4% and EBIT 12.5–13.5%.
The Nomination Committee recommends reelecting nine directors and electing Cecilia Felton as new board member.
Short positions in radiation therapy system company Elekta have increased sharply since March – and on Friday the proportion of shorted shares is at the highest level in eleven years.
Elekta's pressured stock received some support on Friday from Christopher Busch, a member of the group management, who bought shares for over a million.
The billionaire and Brummer veteran Per Josefsson steps in heavily in Elekta. Through investment company Jofam, he bought shares for nearly SEK 220 million this week. "We think that...
The radiation therapy company Elekta fell 7% on Wednesday after presenting new financial targets. Management has implemented a number of measures to get both growth and margins in order.
Track Elekta and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.